Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2

AIRO Giovani - Italian Association of Radiation Oncology-Young Members and AIMN -Italian Association of Nuclear Medicine- Young Members Working Group

doi:10.1016/j.critrevonc.2019.03.008

Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2

AIRO Giovani - Italian Association of Radiation Oncology-Young Members and AIMN -Italian Association of Nuclear Medicine- Young Members Working Group

www.neuromed.it

Research output: Contribution to journal › Review article

Abstract

AIM: Positron Emission Tomography with Computed Tomography (PET/CT) has been proven to be useful in the definition of Radiotherapy (RT) target volume. In this regard, the present expert review summarizes existing data for pancreas, prostate, gynecological and rectum/anal cancer.

METHODS: A comprehensive search of published original article was made, based on SCOPUS and PubMed database, selecting the paper that evaluated the role of PET/CT in the definition of RT volume.

RESULTS: FDG-PET has an important and promising role for pancreatic cancer. Choline PET/CT could be useful for identifying high-risk volumes for prostate cancer; while PSMA PET/CT is still under evaluation. FDG PET/CT in gynecological cancers has been shown to impact external-beam RT planning. The role of FDG-PET for Gross Tumor volume identification is crucial, representing a useful and powerful tool for anal and rectal cancer.

CONCLUSION: Taken together, molecular and functional imaging approaches offer a major step to individualize radiotherapeutic approach.

Original language	English
Pages (from-to)	117-124
Number of pages	8
Journal	Critical Reviews in Oncology/Hematology
Volume	139
DOIs	https://doi.org/10.1016/j.critrevonc.2019.03.008
Publication status	Published - Jul 2019

Keywords

Humans
Image Processing, Computer-Assisted/methods
Neoplasms/diagnostic imaging
Positron Emission Tomography Computed Tomography/methods
Radiotherapy Planning, Computer-Assisted/methods
Radiotherapy, Image-Guided/methods

Access to Document

10.1016/j.critrevonc.2019.03.008

Fingerprint Dive into the research topics of 'Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2'. Together they form a unique fingerprint.

Cite this

AIRO Giovani - Italian Association of Radiation Oncology-Young Members and AIMN -Italian Association of Nuclear Medicine- Young Members Working Group (2019). Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2. Critical Reviews in Oncology/Hematology, 139, 117-124. https://doi.org/10.1016/j.critrevonc.2019.03.008

Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume : PART 2. / AIRO Giovani - Italian Association of Radiation Oncology-Young Members and AIMN -Italian Association of Nuclear Medicine- Young Members Working Group.

In: Critical Reviews in Oncology/Hematology, Vol. 139, 07.2019, p. 117-124.

Research output: Contribution to journal › Review article

AIRO Giovani - Italian Association of Radiation Oncology-Young Members and AIMN -Italian Association of Nuclear Medicine- Young Members Working Group 2019, 'Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2', Critical Reviews in Oncology/Hematology, vol. 139, pp. 117-124. https://doi.org/10.1016/j.critrevonc.2019.03.008

AIRO Giovani - Italian Association of Radiation Oncology-Young Members and AIMN -Italian Association of Nuclear Medicine- Young Members Working Group. Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2. Critical Reviews in Oncology/Hematology. 2019 Jul;139:117-124. https://doi.org/10.1016/j.critrevonc.2019.03.008

AIRO Giovani - Italian Association of Radiation Oncology-Young Members and AIMN -Italian Association of Nuclear Medicine- Young Members Working Group. / Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume : PART 2. In: Critical Reviews in Oncology/Hematology. 2019 ; Vol. 139. pp. 117-124.

@article{07bd0800a75a45548df903ddafe400d6,

title = "Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 2",

abstract = "AIM: Positron Emission Tomography with Computed Tomography (PET/CT) has been proven to be useful in the definition of Radiotherapy (RT) target volume. In this regard, the present expert review summarizes existing data for pancreas, prostate, gynecological and rectum/anal cancer.METHODS: A comprehensive search of published original article was made, based on SCOPUS and PubMed database, selecting the paper that evaluated the role of PET/CT in the definition of RT volume.RESULTS: FDG-PET has an important and promising role for pancreatic cancer. Choline PET/CT could be useful for identifying high-risk volumes for prostate cancer; while PSMA PET/CT is still under evaluation. FDG PET/CT in gynecological cancers has been shown to impact external-beam RT planning. The role of FDG-PET for Gross Tumor volume identification is crucial, representing a useful and powerful tool for anal and rectal cancer.CONCLUSION: Taken together, molecular and functional imaging approaches offer a major step to individualize radiotherapeutic approach.",

keywords = "Humans, Image Processing, Computer-Assisted/methods, Neoplasms/diagnostic imaging, Positron Emission Tomography Computed Tomography/methods, Radiotherapy Planning, Computer-Assisted/methods, Radiotherapy, Image-Guided/methods",

author = "{AIRO Giovani - Italian Association of Radiation Oncology-Young Members and AIMN -Italian Association of Nuclear Medicine- Young Members Working Group} and Alba Fiorentino and Riccardo Laudicella and Elisa Ciurlia and Salvatore Annunziata and Valentina Lancellotta and Paola Mapelli and Carmelo Tuscano and Federico Caobelli and Laura Evangelista and Lorenza Marino and Natale Quartuccio and Michele Fiore and Paolo Borghetti and Agostino Chiaravalloti and Maria Ricci and Isacco Desideri and Pierpaolo Alongi",

year = "2019",

month = jul,

doi = "10.1016/j.critrevonc.2019.03.008",

language = "English",

volume = "139",

pages = "117--124",

journal = "Critical Reviews in Oncology/Hematology",

issn = "1040-8428",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume

T2 - PART 2

AU - AIRO Giovani - Italian Association of Radiation Oncology-Young Members and AIMN -Italian Association of Nuclear Medicine- Young Members Working Group

AU - Fiorentino, Alba

AU - Laudicella, Riccardo

AU - Ciurlia, Elisa

AU - Annunziata, Salvatore

AU - Lancellotta, Valentina

AU - Mapelli, Paola

AU - Tuscano, Carmelo

AU - Caobelli, Federico

AU - Evangelista, Laura

AU - Marino, Lorenza

AU - Quartuccio, Natale

AU - Fiore, Michele

AU - Borghetti, Paolo

AU - Chiaravalloti, Agostino

AU - Ricci, Maria

AU - Desideri, Isacco

AU - Alongi, Pierpaolo

PY - 2019/7

Y1 - 2019/7

N2 - AIM: Positron Emission Tomography with Computed Tomography (PET/CT) has been proven to be useful in the definition of Radiotherapy (RT) target volume. In this regard, the present expert review summarizes existing data for pancreas, prostate, gynecological and rectum/anal cancer.METHODS: A comprehensive search of published original article was made, based on SCOPUS and PubMed database, selecting the paper that evaluated the role of PET/CT in the definition of RT volume.RESULTS: FDG-PET has an important and promising role for pancreatic cancer. Choline PET/CT could be useful for identifying high-risk volumes for prostate cancer; while PSMA PET/CT is still under evaluation. FDG PET/CT in gynecological cancers has been shown to impact external-beam RT planning. The role of FDG-PET for Gross Tumor volume identification is crucial, representing a useful and powerful tool for anal and rectal cancer.CONCLUSION: Taken together, molecular and functional imaging approaches offer a major step to individualize radiotherapeutic approach.

AB - AIM: Positron Emission Tomography with Computed Tomography (PET/CT) has been proven to be useful in the definition of Radiotherapy (RT) target volume. In this regard, the present expert review summarizes existing data for pancreas, prostate, gynecological and rectum/anal cancer.METHODS: A comprehensive search of published original article was made, based on SCOPUS and PubMed database, selecting the paper that evaluated the role of PET/CT in the definition of RT volume.RESULTS: FDG-PET has an important and promising role for pancreatic cancer. Choline PET/CT could be useful for identifying high-risk volumes for prostate cancer; while PSMA PET/CT is still under evaluation. FDG PET/CT in gynecological cancers has been shown to impact external-beam RT planning. The role of FDG-PET for Gross Tumor volume identification is crucial, representing a useful and powerful tool for anal and rectal cancer.CONCLUSION: Taken together, molecular and functional imaging approaches offer a major step to individualize radiotherapeutic approach.

KW - Humans

KW - Image Processing, Computer-Assisted/methods

KW - Neoplasms/diagnostic imaging

KW - Positron Emission Tomography Computed Tomography/methods

KW - Radiotherapy Planning, Computer-Assisted/methods

KW - Radiotherapy, Image-Guided/methods

U2 - 10.1016/j.critrevonc.2019.03.008

DO - 10.1016/j.critrevonc.2019.03.008

M3 - Review article

C2 - 30940428

VL - 139

SP - 117

EP - 124

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

ER -